• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, July 28, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Beatson Foundation awards grant to Boston College biologist Emrah Altindis for Type 1 diabetes research

Bioengineer by Bioengineer
August 1, 2023
in Health
Reading Time: 3 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Chestnut Hill, Mass. (08/01/2023 – Boston College Assistant Professor of Biology Emrah Altindis has received a two-year, $275,000-grant from the Beatson Foundation to explore the role of gut microbes and viruses triggering the autoimmunity of Type 1 diabetes.

Boston College biologist Emrah Altindis

Credit: Lee Pellegrini/Boston College

Chestnut Hill, Mass. (08/01/2023 – Boston College Assistant Professor of Biology Emrah Altindis has received a two-year, $275,000-grant from the Beatson Foundation to explore the role of gut microbes and viruses triggering the autoimmunity of Type 1 diabetes.

“Our lab is extremely grateful for the generous funding bestowed upon us by the Beatson Foundation,” Altindis said. “The receipt of this grant has evoked a profound sense of both excitement and gratitude within our team. We recognize the significant impact this funding will have on our research endeavors, particularly in the field of Type 1 Diabetes.”

Funding for the project, titled “Determine the Role of Microbiota-Derived Insulin Epitope Mimics in Type 1 Diabetes Onset,” will support the Altindis lab’s effort to advance investigations on the potential link between gut microbes and Type 1 Diabetes, leading to a better understanding of the complex disease and potentially opening new avenues for therapeutic interventions including prevention, Altindis said.

Type 1 Diabetes (T1D) is a condition where the body mistakenly attacks and destroys cells that produce insulin, resulting in high blood sugar levels, Altinidis explained. Currently, there is no cure or effective way to prevent T1D. Altindis’s research focuses on understanding why T1D occurs and finding potential ways to treat or prevent it.

“We suspect that a protein similar to insulin, found in certain bacteria that reside in the human gut, may be triggering the onset of T1D,” Altindis said. “Specifically, we are interested in a small part of the insulin protein called insB:9-23. We have discovered a similar peptide called hprt4-18 in a bacterium called Parabacteroides distasonis, which is commonly found in the human gut.”

In previous studies, Altindis and his team have found that immune cells that target insB:9-23 cannot distinguish between the insB:9-23 peptide and the hprt4-18 peptide. When the researchers immunized mice with hprt4-18, their immune cells attacked insB:9-23, showing that T-cells (a type of immune cell) cannot tell the difference between the two. Additionally, when the researchers introduced Parabacteroides distasonis into the gut of mice that are commonly used in T1D research, they observed that T1D developed more quickly and there was increased inflammation.

Further analyzing data from children with T1D, Altindis and his team found a significant connection between the presence of the hprt4-18 peptide in their gut and their risk of developing T1D.

“Building on our previous work, we aim to investigate further whether hprt4-18 derived from the gut microbiota is a cause of T1D,” he said. “Our next steps involve creating a version of the bacteria without hprt4-18 and studying its impact on T1D in different mouse models. We will also use innovative sequencing methods and unique human samples to study how this bacterium affects the human immune response. Lastly, we will examine the presence of immune cells specific to hprt4-18 in both T1D patients and healthy individuals.” 

Altindis hopes this study will help establish a connection between the gut microbiome and T1D, potentially leading to new therapies for the prevention or cure of T1D.

“Our goal is to expand our understanding of T1D and explore new ways to treat or prevent this condition,” Altindis said.

“I would like to express my deep gratitude to the members of my laboratory who have played instrumental roles in the progress of this project,” Altindis said. “In particular, I extend my appreciation to Dr. Khyati Girdhar and Dr. Qian Huang for their valuable contributions and expertise. Furthermore, I would like to acknowledge the efforts of my graduate students, Audrey Randall, Dogus Dogru, and Katherine Truelson. The collaborative spirit and collective contributions of these individuals have been instrumental in driving the success of this project. Lastly, I would like to thank our collaborators who have supported this project. We are truly honored and appreciative of the Beatson Foundation’s recognition and endorsement of our work.”



Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Epicardial Fat: Protector or Threat to Heart Health?

July 26, 2025
blank

Glymphatic Asymmetry Linked to Parkinson’s Onset Side

July 26, 2025

Theta Stimulation Boosts Conflict Resolution in Parkinson’s

July 26, 2025

Faecal Transplants Show Safety in Parkinson’s Pilot

July 26, 2025

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    53 shares
    Share 21 Tweet 13
  • USF Research Unveils AI Technology for Detecting Early PTSD Indicators in Youth Through Facial Analysis

    42 shares
    Share 17 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    45 shares
    Share 18 Tweet 11
  • Engineered Cellular Communication Enhances CAR-T Therapy Effectiveness Against Glioblastoma

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Decoding FLS2 Unveils Broad Pathogen Detection Principles

Advanced Pressure-Velocity Patch Enhances Flight Detection

Durable, Flexible Electrochemical Transistors via Electropolymerized PEDOT

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.